Assignee
GLAXOSMITHKLINE LLC
US182 patents
Top patents by PatentIndex Score
USD747478SJan 12, 2016
Nasal dilator
GLAXOSMITHKLINE LLC51 citations97
USD644324SAug 30, 2011
Nasal dilator
GLAXOSMITHKLINE LLC92 citations97
USD644325SAug 30, 2011
Nasal dilator
GLAXOSMITHKLINE LLC93 citations97
US7982005B2Jul 19, 2011
Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
GLAXOSMITHKLINE LLC44 citations96
USD639762SJun 14, 2011
Nasal dilator
GLAXOSMITHKLINE LLC96 citations96
USD827442SSep 4, 2018
Bottle with cap
GLAXOSMITHKLINE LLC18 citations93
US9901479B2Feb 27, 2018
External nasal dilator and methods
GLAXOSMITHKLINE LLC25 citations92
US9662336B2May 30, 2017
Pyrazolopyrimidine compounds
GLAXOSMITHKLINE LLC19 citations92
US9173872B2Nov 3, 2015
Pyrazolopyrimidine compounds
GLAXOSMITHKLINE LLC11 citations92
US7683056B2Mar 23, 2010
Pyridine derivatives and their use in the treatment of psychotic disorders
GLAXOSMITHKLINE LLC19 citations92
US7661423B2Feb 16, 2010
Device housing for an aerosol container
GLAXOSMITHKLINE LLC30 citations92
US8815884B2Aug 26, 2014
Prolyl hydroxylase inhibitors
GLAXOSMITHKLINE LLC9 citations91
US8975291B2Mar 10, 2015
Indoles
GLAXOSMITHKLINE LLC12 citations90
US7834063B2Nov 16, 2010
Benzonitryl and nitrobenzyl derivatives that modulate androgen receptors
GLAXOSMITHKLINE LLC28 citations90
USRE41555EAug 24, 2010
Antibody purification
GLAXOSMITHKLINE LLC13 citations90
USD733552SJul 7, 2015
Package
GLAXOSMITHKLINE LLC20 citations89
USRE41595EAug 31, 2010
Antibody purification
GLAXOSMITHKLINE LLC16 citations88
USD626417SNov 2, 2010
Container
GLAXOSMITHKLINE LLC38 citations86
USD625192SOct 12, 2010
Container
GLAXOSMITHKLINE LLC33 citations86
US7897612B2Mar 1, 2011
Substituted 1,8-naphthyridinecarboxamides for use as prolyl hydroxylase inhibitors
GLAXOSMITHKLINE LLC27 citations85
US9877968B2Jan 30, 2018
6-amino-purin-8-one compounds
GLAXOSMITHKLINE LLC3 citations84
US9102685B2Aug 11, 2015
Derivatives of betulin
GLAXOSMITHKLINE LLC8 citations84
US8785433B2Jul 22, 2014
Quinoline derivatives as PI3 kinase inhibitors
GLAXOSMITHKLINE LLC9 citations84
US7795293B2Sep 14, 2010
3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
GLAXOSMITHKLINE LLC10 citations84
US7767701B2Aug 3, 2010
Chemical compounds
GLAXOSMITHKLINE LLC13 citations84
USD830842SOct 16, 2018
Bottle
GLAXOSMITHKLINE LLC7 citations83
US9562041B2Feb 7, 2017
Enhancer of zeste homolog 2 inhibitors
GLAXOSMITHKLINE LLC13 citations83
US9114141B2Aug 25, 2015
Indoles
GLAXOSMITHKLINE LLC4 citations83
US8802684B2Aug 12, 2014
Adenine derivatives
GLAXOSMITHKLINE LLC13 citations83
US10035779B2Jul 31, 2018
Prolyl hydroxylase inhibitors
GLAXOSMITHKLINE LLC3 citations82
US9382234B2Jul 5, 2016
Enhancer of Zeste Homolog 2 inhibitors
GLAXOSMITHKLINE LLC8 citations82
US8557834B2Oct 15, 2013
Prolyl hydroxylase inhibitors
GLAXOSMITHKLINE LLC8 citations82
US8052995B2Nov 8, 2011
3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene] hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
GLAXOSMITHKLINE LLC8 citations82
US8052994B2Nov 8, 2011
3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene] hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
GLAXOSMITHKLINE LLC9 citations82
US8052993B2Nov 8, 2011
3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
GLAXOSMITHKLINE LLC7 citations82
US7989395B2Aug 2, 2011
Methods for identifying compounds of interest using encoded libraries
GLAXOSMITHKLINE LLC15 citations82
US7972994B2Jul 5, 2011
Methods for synthesis of encoded libraries
GLAXOSMITHKLINE LLC9 citations82
USD775945SJan 10, 2017
Package
GLAXOSMITHKLINE LLC6 citations81
US8952018B2Feb 10, 2015
Pharmaceutical combination of MEK inhibitor and B-Raf inhibitors
GLAXOSMITHKLINE LLC13 citations81
USD704048SMay 6, 2014
Package
GLAXOSMITHKLINE LLC7 citations81
US8026262B2Sep 27, 2011
Chemical compounds
GLAXOSMITHKLINE LLC7 citations81
USD744328SDec 1, 2015
Container
GLAXOSMITHKLINE LLC15 citations80
US8492554B2Jul 23, 2013
Chemical compounds
GLAXOSMITHKLINE LLC5 citations80
US8354406B2Jan 15, 2013
Chemical compounds
GLAXOSMITHKLINE LLC6 citations80
US7977344B2Jul 12, 2011
Compounds
GLAXOSMITHKLINE LLC15 citations80
US7812022B2Oct 12, 2010
2-pyrimidinyl pyrazolopyridine ErbB kinase inhibitors
GLAXOSMITHKLINE LLC8 citations80
US7709677B2May 4, 2010
Process of preparing arylethanoldiamines
GLAXOSMITHKLINE LLC14 citations80
US7829297B2Nov 9, 2010
Treatment of cancers expressing p95 ErbB2
GLAXOSMITHKLINE LLC16 citations77
US7828150B2Nov 9, 2010
Container for medicament powder
GLAXOSMITHKLINE LLC14 citations77
US8912205B2Dec 16, 2014
Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
GLAXOSMITHKLINE LLC3 citations74
Showing the top 50 of 182 patents by PatentIndex Score.